Skip to main content
Erschienen in: European Journal of Epidemiology 2/2016

16.06.2015 | GENETIC EPIDEMIOLOGY

Clinical findings and diagnosis in genetic prion diseases in Germany

verfasst von: Anna Krasnianski, Uta Heinemann, Claudia Ponto, Jasmine Kortt, Kai Kallenberg, Daniela Varges, Walter J. Schulz-Schaeffer, Hans A. Kretzschmar, Inga Zerr

Erschienen in: European Journal of Epidemiology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

To describe the clinical syndrome and diagnostic tests in patients with genetic prion diseases (gPD) in Germany. Clinical features, MRI, EEG, and CSF markers were studied in 91 patients (28 D178N, 20 E200K, 17 inserts, 13 V210I, 8 P102L, 5 E196K). Dementia (35 %) and ataxia (29 %) were the most common initial symptoms and signs. A wide variety and high frequency of neurological/psychiatric symptoms and signs was found during disease course in all patients independently of the type of the mutation. Psychiatric manifestations were frequent (87 %). Neuropsychological abnormalities were observed in 67 %, and aphasia was the most common disturbance (45 %). In E200K, V210I and D178N patients, visual/oculomotor deficits were followed by ataxia early in the disease. Dementia followed by ataxia at onset was common in patients with insert and E196K mutation. P102L patients had isolated ataxia over a longer time period followed by pyramidal signs. Dementia was present only late in the disease course. All clinical routine tests such as MRI, EEG and CSF tests were less sensitive than in sporadic CJD. We provide the first detailed analysis of clinical signs and symptoms in a large group of patients with gPD. Frequency of clinical symptoms and signs was similar in different mutations in a later disease course, but the sequence of occurrence may be of great diagnostic importance. CSF markers were shown to be more sensitive than MRI and EEG.
Literatur
1.
Zurück zum Zitat Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, Van Duijn C, Collins S, Boyd A, Guilivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar H, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166–74.CrossRefPubMed Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, Van Duijn C, Collins S, Boyd A, Guilivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar H, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166–74.CrossRefPubMed
2.
Zurück zum Zitat Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA. Molecular genetics of human prion diseases in Germany. Hum Genet. 1999;105:244–52.CrossRefPubMed Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA. Molecular genetics of human prion diseases in Germany. Hum Genet. 1999;105:244–52.CrossRefPubMed
3.
Zurück zum Zitat Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P. Fatal familial insomnia and familial Creutzfeldt–Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–8.CrossRefPubMed Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P. Fatal familial insomnia and familial Creutzfeldt–Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–8.CrossRefPubMed
4.
Zurück zum Zitat Zarranz JJ, Digon A, Atares B, Rodriguez-Martinez AB, Arce A, Carrera N, Fernandez-Manchola I, Fernandez-Martinez M, Fernandez-Maiztegui C, Forcadas I, Galdos L, Gomez-Esteban JC, Ibanez A, Lezcano E, Lopez de Munain A, Marti-Masso JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, de Pancorbo MM. Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry. 2005;76(11):1491–6.CrossRefPubMedPubMedCentral Zarranz JJ, Digon A, Atares B, Rodriguez-Martinez AB, Arce A, Carrera N, Fernandez-Manchola I, Fernandez-Martinez M, Fernandez-Maiztegui C, Forcadas I, Galdos L, Gomez-Esteban JC, Ibanez A, Lezcano E, Lopez de Munain A, Marti-Masso JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, de Pancorbo MM. Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry. 2005;76(11):1491–6.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Gambetti P, Kong Q, Zou W, Parchi P, Chen S. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213–39.CrossRefPubMed Gambetti P, Kong Q, Zou W, Parchi P, Chen S. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213–39.CrossRefPubMed
6.
Zurück zum Zitat Lee HS, Sambuughin N, Cervenakova L, Chapman J, Pocchiari M, Litvak S, Qi HY, Budka H, del Ser T, Furukawa H, Brown P, Gajdusek DC, Long JC, Korczyn AD, Goldfarb LG. Ancestral origins and worldwide distribution of the PRNP 200 K mutation causing familial Creutzfeldt–Jakob disease. Am J Hum Genet. 1999;64(4):1063–70.CrossRefPubMedPubMedCentral Lee HS, Sambuughin N, Cervenakova L, Chapman J, Pocchiari M, Litvak S, Qi HY, Budka H, del Ser T, Furukawa H, Brown P, Gajdusek DC, Long JC, Korczyn AD, Goldfarb LG. Ancestral origins and worldwide distribution of the PRNP 200 K mutation causing familial Creutzfeldt–Jakob disease. Am J Hum Genet. 1999;64(4):1063–70.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel J-P, Poser S, Kretzschmar H, Rietveld I, Mitrova E, de Pedro-Cuesta J, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I. Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586–91.CrossRefPubMed Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel J-P, Poser S, Kretzschmar H, Rietveld I, Mitrova E, de Pedro-Cuesta J, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I. Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586–91.CrossRefPubMed
8.
Zurück zum Zitat Gao C, Shi Q, Tian C, Chen C, Han J, Zhou w, Zhang BY, Jiang HY, Zhang J, Dong XP. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt–Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231. Gao C, Shi Q, Tian C, Chen C, Han J, Zhou w, Zhang BY, Jiang HY, Zhang J, Dong XP. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt–Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231.
9.
Zurück zum Zitat Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens C, Van Duijn C, Zerr I. CSF tests in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology. 2006;67(4):637–43.CrossRefPubMed Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens C, Van Duijn C, Zerr I. CSF tests in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology. 2006;67(4):637–43.CrossRefPubMed
10.
Zurück zum Zitat Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol. 2009;256(10):1620–8.CrossRefPubMedPubMedCentral Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol. 2009;256(10):1620–8.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–33.CrossRefPubMed Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–33.CrossRefPubMed
12.
Zurück zum Zitat Krasnianski A, Bartl M, Sanchez-Juan PJ, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar HA, Schulz-Schaeffer WJ, Zerr I. Fatal familial insomnia: clinical features and early identification. Ann Neurol. 2008;63:658–61.CrossRefPubMed Krasnianski A, Bartl M, Sanchez-Juan PJ, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar HA, Schulz-Schaeffer WJ, Zerr I. Fatal familial insomnia: clinical features and early identification. Ann Neurol. 2008;63:658–61.CrossRefPubMed
13.
Zurück zum Zitat WHO. Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec. 1998;47:361–5. WHO. Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec. 1998;47:361–5.
14.
Zurück zum Zitat Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Fletcher A, Bodemer M, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology. 2000;55:811–5.CrossRefPubMed Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Fletcher A, Bodemer M, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology. 2000;55:811–5.CrossRefPubMed
15.
Zurück zum Zitat Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie DA, Smith P, Varges D, Heinemann U, Meissner B, Roberts H, Brandel JP, Van Dujin CM, Pocchiari M, Begue P, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain. 2009;132:2659–68.CrossRefPubMedPubMedCentral Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie DA, Smith P, Varges D, Heinemann U, Meissner B, Roberts H, Brandel JP, Van Dujin CM, Pocchiari M, Begue P, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain. 2009;132:2659–68.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt–Jakob disease. Arch Neurol. 1996;53(2):162–6.CrossRefPubMed Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt–Jakob disease. Arch Neurol. 1996;53(2):162–6.CrossRefPubMed
17.
Zurück zum Zitat Kitamoto T, Doh uK, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol. 1992;141(2):271–7. Kitamoto T, Doh uK, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol. 1992;141(2):271–7.
18.
Zurück zum Zitat Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Arch Neurol. 1996;53(9):913–20.CrossRefPubMed Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Arch Neurol. 1996;53(9):913–20.CrossRefPubMed
19.
Zurück zum Zitat Schulz-Schaeffer WJ, Zerr I, Windl O, Giese A, Poser S, Kretzschmar HA. Moleculargenetic determination of the disease phenotype in sporadic Creutzfeldt–Jakob disease. Infection. 2000;28(Suppl 1):25. Schulz-Schaeffer WJ, Zerr I, Windl O, Giese A, Poser S, Kretzschmar HA. Moleculargenetic determination of the disease phenotype in sporadic Creutzfeldt–Jakob disease. Infection. 2000;28(Suppl 1):25.
20.
Zurück zum Zitat Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt–Jakob disease. Ann Neurol. 1998;43(1):32–40.CrossRefPubMed Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt–Jakob disease. Ann Neurol. 1998;43(1):32–40.CrossRefPubMed
21.
Zurück zum Zitat Krasnianski A, Kaune J, Jung K, Kretzschmar H, Zerr I. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol. 2014;261(9):1811–7.CrossRefPubMed Krasnianski A, Kaune J, Jung K, Kretzschmar H, Zerr I. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol. 2014;261(9):1811–7.CrossRefPubMed
22.
Zurück zum Zitat Karch A, Raddaz LM, Ponto C, Hermann P, Summers DM, Zerr I. Diagnostic profiles of patients with late-onset Creutzfeldt–Jakob disease differ from those of younger Creutzfeldt–Jakob patients: a historical cohort study using data from the German National Reference Center. J Neurol. 2014;261(5):877–83.CrossRefPubMed Karch A, Raddaz LM, Ponto C, Hermann P, Summers DM, Zerr I. Diagnostic profiles of patients with late-onset Creutzfeldt–Jakob disease differ from those of younger Creutzfeldt–Jakob patients: a historical cohort study using data from the German National Reference Center. J Neurol. 2014;261(5):877–83.CrossRefPubMed
23.
Zurück zum Zitat Mead S, Poulter M, Beck J, Webb T, Campbell T, Linehan J, Desbruslais M, Joiner S, Wadsworth JD, King A, Lantos P, Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation- molecular analysis of phenotypic heterogeneity. Brain. 2006;129(9):2297–317.CrossRefPubMed Mead S, Poulter M, Beck J, Webb T, Campbell T, Linehan J, Desbruslais M, Joiner S, Wadsworth JD, King A, Lantos P, Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation- molecular analysis of phenotypic heterogeneity. Brain. 2006;129(9):2297–317.CrossRefPubMed
24.
Zurück zum Zitat Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt–Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350–9.CrossRefPubMed Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt–Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350–9.CrossRefPubMed
25.
Zurück zum Zitat Webb TE, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe SJ, Collinge J, Mead S. Phenotypic heterogeneity and genetic modifications of P102L inherited prion disease in an international series. Brain. 2008;131(10):2632–46.CrossRefPubMedPubMedCentral Webb TE, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe SJ, Collinge J, Mead S. Phenotypic heterogeneity and genetic modifications of P102L inherited prion disease in an international series. Brain. 2008;131(10):2632–46.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene. Phenotypic spectrum. J Neurol. 2002;249(11):1567–82.CrossRefPubMed Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene. Phenotypic spectrum. J Neurol. 2002;249(11):1567–82.CrossRefPubMed
27.
Zurück zum Zitat Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled study. Am J Neuroradiol. 2008;29(9):1638–43.CrossRefPubMed Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled study. Am J Neuroradiol. 2008;29(9):1638–43.CrossRefPubMed
28.
Zurück zum Zitat Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R, Rosenmann H. Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel. J Neurol. 2011;258(2):255–62.CrossRefPubMed Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R, Rosenmann H. Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel. J Neurol. 2011;258(2):255–62.CrossRefPubMed
29.
Zurück zum Zitat Meissner B, Köhler K, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I. Sporadic Creutzfeldt–Jakob disease: magnetic resonance imaging and clinical findings. Neurology. 2004;63:450–6.CrossRefPubMed Meissner B, Köhler K, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I. Sporadic Creutzfeldt–Jakob disease: magnetic resonance imaging and clinical findings. Neurology. 2004;63:450–6.CrossRefPubMed
Metadaten
Titel
Clinical findings and diagnosis in genetic prion diseases in Germany
verfasst von
Anna Krasnianski
Uta Heinemann
Claudia Ponto
Jasmine Kortt
Kai Kallenberg
Daniela Varges
Walter J. Schulz-Schaeffer
Hans A. Kretzschmar
Inga Zerr
Publikationsdatum
16.06.2015
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 2/2016
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-015-0049-y

Weitere Artikel der Ausgabe 2/2016

European Journal of Epidemiology 2/2016 Zur Ausgabe